Less care at higher cost - The Medicare Advantage paradox

Less care at higher cost - The Medicare Advantage paradox
JAMA Internal Medicine; by Adam Gaffney, MD, MPH, Stephanie Woolhandler, MD, MPH, David U. Himmelstein, MD; 6/24
Celebrating a Medicare Advantage (MA) milestone—enrollment in those private plans surpassed 30 million—the health insurance industry’s trade group proclaimed MA “a good deal for members and taxpayers.” The first part of that claim is debatable, while the second part is false. Medicare Payment Advisory Commission (MedPAC), the nonpartisan agency reporting to Congress, recently estimated that MA overpayments added $82 billion to taxpayers’ costs for Medicare in 2023 and $612 billion between 2007 and 2024.
Publisher's Note: "You're getting less care, but at least it costs more" is right in line with my mantra "I may be old, but at least I'm slow"...